Shanghai MicroPort Lifesciences Co., Ltd. (hereinafter referred to as "MicroPort Lifesciences") was established on April 28, 2008 by MicroPort Medical Devices (Shanghai) Co. (hereinafter referred to as "Wicresoft") was invested and established on April 28, 2008 in the Industrial, Academic and Research Base of Shanghai International Medical Park (Medical Valley - Modern Business Park). Wicresoft's main business is the research, development, production and operation of various medical devices related to the monitoring and treatment of diabetes.
MicroPort Lifesciences (Beijing) Co., Ltd. was formerly known as Beijing Pangere Medical Device Technology Co. It is a high-tech enterprise company in Zhongguancun Science and Technology Park in Beijing, with modernized production purification workshop and advanced equipments in line with international standards, a scientific research team composed of experts in medicine, electronics, precision instruments and biology, and professional sales staff with solid medical foundation and excellent business quality.
Shanghai MicroPort Orthopedics Co., Ltd. (hereinafter referred to as "MicroPort Orthopedics") was established on May 18, 2009 in Shanghai International Medical Park (SIMP) under the diversified development strategy of MicroPort Medical Devices (Shanghai) Co. (hereinafter referred to as "Wicresoft Orthopaedics") is a wholly-owned subsidiary of Wicresoft Medical Devices (Shanghai) Co. The main business of Wicresoft Orthopaedics is to develop, manufacture and sell implantable products, devices and biomaterials for the human spine and new trauma products. The company has a specialized research and development team, and the production base in Shanghai International Medical Park is equipped with precise and highly automated processing equipment production lines and testing equipment, as well as non-destructive testing laboratories, physical laboratories, chemical analysis laboratories and other specialized testing laboratories, and has a clean room that meets the national standards for the production of Class III implantable products.
Shanghai MicroPort EP MedTech Co., Ltd. (hereinafter referred to as "MicroPort EP") was established on August 31, 2010 by MicroPort Medical Devices (Shanghai) Co. ("Wicresoft Electrophysiology") was established on August 31, 2010 by Wicresoft Medical Devices (Shanghai) Co. Wicresoft's main business is the research, development, production and operation of various medical devices and equipment related to cardiac electrophysiology interventional diagnosis and treatment, including ablation catheters, diagnostic catheters, 3D cardiac electrophysiology calibration system and other series of products.